Home
About IBT
Vision and Mission
IBT History
Management
Board of Directors
Advisory Board
Families
Health Care Professionals
Pipeline
IBP-9414
IBP-1016
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
Vision and Mission
IBT History
Management
Board of Directors
Advisory Board
Families
Health Care Professionals
Pipeline
IBP-9414
IBP-1016
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
Outcome of Infant Bacterial Therapeutics’ rights issue
To access the press release, please read the following disclaimer
here
.
February 2, 2018
Latest press releases
Next recruitment milestone reached in IBT’s Phase III Study.
After safety review The Connection study is now again open to recruit the smallest infants.
Infant Bacterial Therapeutics today announces that a new patent is granted in Mexico
Recruitment of the smallest infants in the Connection study paused
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2021
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience.
Find out more.
Okay, thanks
